United States BCG Vaccine Market Report & Forecast 2021-2027

Publisher Name :
Date: 09-Sep-2021
No. of pages: 93
Inquire Before Buying

United States BCG Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT)

United States BCG Vaccine Market Segment Percentages, By Type, 2020 (%)

- Immune BCG

- Therapy BCG

United States BCG Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT)

United States BCG Vaccine Market Segment Percentages, By Application, 2020 (%)

- Hospitals

- Clinics

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies BCG Vaccine revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies BCG Vaccine revenues share in United States market, 2020 (%)

Key companies BCG Vaccine sales in United States market, 2016-2021 (Estimated), (MT)

Key companies BCG Vaccine sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Merck

- Sanofi Pasteur

- Japan BCG Lab

- China National Biotec

- Serum Institute of India

- Intervax

- GSBPL

United States BCG Vaccine Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 BCG Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States BCG Vaccine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States BCG Vaccine Overall Market Size
2.1 United States BCG Vaccine Market Size: 2021 VS 2027
2.2 United States BCG Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 United States BCG Vaccine Sales: 2016-2027
3 Company Landscape
3.1 Top BCG Vaccine Players in United States Market
3.2 Top United States BCG Vaccine Companies Ranked by Revenue
3.3 United States BCG Vaccine Revenue by Companies
3.4 United States BCG Vaccine Sales by Companies
3.5 United States BCG Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 BCG Vaccine Companies in United States Market, by Revenue in 2020
3.7 Manufacturers BCG Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 BCG Vaccine Players in United States Market
3.8.1 List of Tier 1 BCG Vaccine Companies in United States
3.8.2 List of Tier 2 and Tier 3 BCG Vaccine Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States BCG Vaccine Market Size Markets, 2021 & 2027
4.1.2 Immune BCG
4.1.3 Therapy BCG
4.2 By Type - United States BCG Vaccine Revenue & Forecasts
4.2.1 By Type - United States BCG Vaccine Revenue, 2016-2021
4.2.2 By Type - United States BCG Vaccine Revenue, 2022-2027
4.2.3 By Type - United States BCG Vaccine Revenue Market Share, 2016-2027
4.3 By Type - United States BCG Vaccine Sales & Forecasts
4.3.1 By Type - United States BCG Vaccine Sales, 2016-2021
4.3.2 By Type - United States BCG Vaccine Sales, 2022-2027
4.3.3 By Type - United States BCG Vaccine Sales Market Share, 2016-2027
4.4 By Type - United States BCG Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States BCG Vaccine Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - United States BCG Vaccine Revenue & Forecasts
5.2.1 By Application - United States BCG Vaccine Revenue, 2016-2021
5.2.2 By Application - United States BCG Vaccine Revenue, 2022-2027
5.2.3 By Application - United States BCG Vaccine Revenue Market Share, 2016-2027
5.3 By Application - United States BCG Vaccine Sales & Forecasts
5.3.1 By Application - United States BCG Vaccine Sales, 2016-2021
5.3.2 By Application - United States BCG Vaccine Sales, 2022-2027
5.3.3 By Application - United States BCG Vaccine Sales Market Share, 2016-2027
5.4 By Application - United States BCG Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Overview
6.1.3 Merck BCG Vaccine Sales and Revenue in United States Market (2016-2021)
6.1.4 Merck BCG Vaccine Product Description
6.1.5 Merck Recent Developments
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Overview
6.2.3 Sanofi Pasteur BCG Vaccine Sales and Revenue in United States Market (2016-2021)
6.2.4 Sanofi Pasteur BCG Vaccine Product Description
6.2.5 Sanofi Pasteur Recent Developments
6.3 Japan BCG Lab
6.3.1 Japan BCG Lab Corporation Information
6.3.2 Japan BCG Lab Overview
6.3.3 Japan BCG Lab BCG Vaccine Sales and Revenue in United States Market (2016-2021)
6.3.4 Japan BCG Lab BCG Vaccine Product Description
6.3.5 Japan BCG Lab Recent Developments
6.4 China National Biotec
6.4.1 China National Biotec Corporation Information
6.4.2 China National Biotec Overview
6.4.3 China National Biotec BCG Vaccine Sales and Revenue in United States Market (2016-2021)
6.4.4 China National Biotec BCG Vaccine Product Description
6.4.5 China National Biotec Recent Developments
6.5 Serum Institute of India
6.5.1 Serum Institute of India Corporation Information
6.5.2 Serum Institute of India Overview
6.5.3 Serum Institute of India BCG Vaccine Sales and Revenue in United States Market (2016-2021)
6.5.4 Serum Institute of India BCG Vaccine Product Description
6.5.5 Serum Institute of India Recent Developments
6.6 Intervax
6.6.1 Intervax Corporation Information
6.6.2 Intervax Overview
6.6.3 Intervax BCG Vaccine Sales and Revenue in United States Market (2016-2021)
6.6.4 Intervax BCG Vaccine Product Description
6.6.5 Intervax Recent Developments
6.7 GSBPL
6.7.1 GSBPL Corporation Information
6.7.2 GSBPL Overview
6.7.3 GSBPL BCG Vaccine Sales and Revenue in United States Market (2016-2021)
6.7.4 GSBPL BCG Vaccine Product Description
6.7.5 GSBPL Recent Developments
7 United States BCG Vaccine Production Capacity, Analysis
7.1 United States BCG Vaccine Production Capacity, 2016-2027
7.2 BCG Vaccine Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 BCG Vaccine Supply Chain Analysis
9.1 BCG Vaccine Industry Value Chain
9.2 BCG Vaccine Upstream Market
9.3 BCG Vaccine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 BCG Vaccine Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of BCG Vaccine in United States Market
Table 2. Top BCG Vaccine Players in United States Market, Ranking by Revenue (2019)
Table 3. United States BCG Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States BCG Vaccine Revenue Share by Companies, 2016-2021
Table 5. United States BCG Vaccine Sales by Companies, (MT), 2016-2021
Table 6. United States BCG Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers BCG Vaccine Price (2016-2021) & (USD/Kg)
Table 8. Manufacturers BCG Vaccine Product Type
Table 9. List of Tier 1 BCG Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 BCG Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Immune BCG
Table 12. Major Manufacturers of Therapy BCG
Table 13. By Type - United States BCG Vaccine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States BCG Vaccine Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States BCG Vaccine Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States BCG Vaccine Sales (MT), 2016-2021
Table 17. By Type - United States BCG Vaccine Sales (MT), 2022-2027
Table 18. By Application - United States BCG Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States BCG Vaccine Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States BCG Vaccine Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States BCG Vaccine Sales (MT), 2016-2021
Table 22. By Application - United States BCG Vaccine Sales (MT), 2022-2027
Table 23. Merck Corporation Information
Table 24. Merck Description and Major Businesses
Table 25. Merck BCG Vaccine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 26. Merck BCG Vaccine Product
Table 27. Merck Recent Developments
Table 28. Sanofi Pasteur Corporation Information
Table 29. Sanofi Pasteur Description and Major Businesses
Table 30. Sanofi Pasteur BCG Vaccine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 31. Sanofi Pasteur BCG Vaccine Product
Table 32. Sanofi Pasteur Recent Developments
Table 33. Japan BCG Lab Corporation Information
Table 34. Japan BCG Lab Description and Major Businesses
Table 35. Japan BCG Lab BCG Vaccine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 36. Japan BCG Lab BCG Vaccine Product
Table 37. Japan BCG Lab Recent Developments
Table 38. China National Biotec Corporation Information
Table 39. China National Biotec Description and Major Businesses
Table 40. China National Biotec BCG Vaccine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 41. China National Biotec BCG Vaccine Product
Table 42. China National Biotec Recent Developments
Table 43. Serum Institute of India Corporation Information
Table 44. Serum Institute of India Description and Major Businesses
Table 45. Serum Institute of India BCG Vaccine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 46. Serum Institute of India BCG Vaccine Product
Table 47. Serum Institute of India Recent Developments
Table 48. Intervax Corporation Information
Table 49. Intervax Description and Major Businesses
Table 50. Intervax BCG Vaccine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 51. Intervax BCG Vaccine Product
Table 52. Intervax Recent Developments
Table 53. GSBPL Corporation Information
Table 54. GSBPL Description and Major Businesses
Table 55. GSBPL BCG Vaccine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 56. GSBPL BCG Vaccine Product
Table 57. GSBPL Recent Developments
Table 58. BCG Vaccine Production Capacity (MT) of Key Manufacturers in United States Market, 2019-2021 (MT)
Table 59. United States BCG Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 60. BCG Vaccine Market Opportunities & Trends in United States Market
Table 61. BCG Vaccine Market Drivers in United States Market
Table 62. BCG Vaccine Market Restraints in United States Market
Table 63. BCG Vaccine Raw Materials
Table 64. BCG Vaccine Raw Materials Suppliers in United States Market
Table 65. Typical BCG Vaccine Downstream
Table 66. BCG Vaccine Downstream Clients in United States Market
Table 67. BCG Vaccine Distributors and Sales Agents in United States Market
List of Figures
Figure 1. BCG Vaccine Product Picture
Figure 2. BCG Vaccine Segment by Type
Figure 3. BCG Vaccine Segment by Application
Figure 4. United States BCG Vaccine Market Overview: 2020
Figure 5. United States BCG Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States BCG Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. BCG Vaccine Sales in United States Market: 2016-2027 (MT)
Figure 8. The Top 3 and 5 Players Market Share by BCG Vaccine Revenue in 2020
Figure 9. Immune BCG Product Picture
Figure 10. Therapy BCG Product Picture
Figure 11. By Type - United States BCG Vaccine Sales Market Share, 2016-2027
Figure 12. By Type - United States BCG Vaccine Revenue Market Share, 2016-2027
Figure 13. By Type - United States BCG Vaccine Price (USD/Kg), 2016-2027
Figure 14. Hospitals
Figure 15. Clinics
Figure 16. Others
Figure 17. By Application - United States BCG Vaccine Sales Market Share, 2016-2027
Figure 18. By Application - United States BCG Vaccine Revenue Market Share, 2016-2027
Figure 19. By Application - United States BCG Vaccine Price (USD/Kg), 2016-2027
Figure 20. Merck BCG Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Sanofi Pasteur BCG Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Japan BCG Lab BCG Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. China National Biotec BCG Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Serum Institute of India BCG Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Intervax BCG Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. GSBPL BCG Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. United States BCG Vaccine Production Capacity (MT), 2016-2027
Figure 28. BCG Vaccine Industry Value Chain
Figure 29. Marketing Channels
  • Global BCG Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global BCG Vaccine market size was valued at US$ 365.6 million in 2023. With growing demand in downstream market, the BCG Vaccine is forecast to a readjusted size of US$ 542.8 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global BCG Vaccine market. BCG Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing cost......
  • Global Peptide Cancer Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Peptide Cancer Vaccine market size was valued at US$ 535 million in 2023. With growing demand in downstream market, the Peptide Cancer Vaccine is forecast to a readjusted size of US$ 1978.2 million by 2030 with a CAGR of 20.5% during review period. The research report highlights the growth potential of the global Peptide Cancer Vaccine market. Peptide Cancer Vaccine are expected to show stable growth in the future market. How......
  • Global Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Cancer Vaccine market: According to our latest research, the global Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Cancer Vaccine market was estimated at USD 7198.2 million, and it's anticipated to reach USD 33936.62 million in 2028, with a CAGR of 29.49% during the forecast years. A cancer vaccine is a type of immunotherapy that boost the body's natural defenses by stimulating the immune system to recognize and cur......
  • Global Lung Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Dec-2023        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Lung Cancer Vaccines market: According to our latest research, the global Lung Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Lung Cancer Vaccines market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Lung Cancer Vaccines,A cancer vaccine for lung cance This report covers a research time span from 2018 to 2028, and ......
  • Global Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 105
    Market Overview of Global Cancer Vaccines market: According to our latest research, the global Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Cancer Vaccines market was estimated at USD 5773.14 million, and it's anticipated to reach USD 15406.41 million in 2028, with a CAGR of 17.77% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Vacci......
  • Global Dendritic Cell Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 110
    Market Overview of Global Dendritic Cell Cancer Vaccine market: According to our latest research, the global Dendritic Cell Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Dendritic Cell Cancer Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Dendritic cells (DC) are one of the major antigen presenting cells found in lymphoid organs. The main fu......
  • Global BCG Vaccine Market Research Report 2023, Forecast to 2028
    Published: 14-Nov-2023        Price: US 2680 Onwards        Pages: 135
    BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......
  • Global BCG Vaccine Professional Survey Report 2023, Forecast to 2028
    Published: 14-Nov-2023        Price: US 3280 Onwards        Pages: 105
    BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......
  • Infectious Vaccine Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 300
    Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the infectious vaccine deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of infectious vaccine deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter infectious vaccine deals. These deals tend to be multicomponent, starting with......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs